+ All Categories
Home > Documents > RIP-Szklo-3-26-09

RIP-Szklo-3-26-09

Date post: 03-Jun-2018
Category:
Upload: nguyen-tuan-anh
View: 220 times
Download: 0 times
Share this document with a friend

of 36

Transcript
  • 8/12/2019 RIP-Szklo-3-26-09

    1/36

    Addressing Reviewers Comments

    and Revising Manuscripts After PeerReview

    Moyses Szklo

    Editor-in-ChiefAmerican Journal of Epidemiology

  • 8/12/2019 RIP-Szklo-3-26-09

    2/36

    EIC believes it should

    be rejected out of hand

    (low priority) 2ndeditor

    Agrees: paper

    is rejected

    Disagrees

    Outside reviews

    Editor believes it should

    go to external reviewers Agrees

    Disagrees

    Changes his mind

    and agrees: paper

    is rejected Disagrees

    Peer Review Process in the American Journal of Epidemiology

    Paper reviewed by EIC

  • 8/12/2019 RIP-Szklo-3-26-09

    3/36

  • 8/12/2019 RIP-Szklo-3-26-09

    4/36

    Primary Prevention

    In a case-based case-control study, odds ratios instead of

    beta coefficients

    In a cross-sectional study or when calculating cumulativeincidence ratio without adjustment for time-to-event,prevalence ratio regression

    Presentation of p values, 95% confidence limits and standarderrors simultaneously is often redundant

    Be careful when comparing association strengths

    Stratified data instead of interaction terms (the latter areuseful for statistical testing and for predictive equations)

  • 8/12/2019 RIP-Szklo-3-26-09

    5/36

  • 8/12/2019 RIP-Szklo-3-26-09

    6/36

    (Spiegelman D, Hertzmark E, Am J Epidemiol 2005;162:199-200)

  • 8/12/2019 RIP-Szklo-3-26-09

    7/36

    Primary Prevention

    In a case-based case-control study, odds ratios instead of

    beta coefficients

    In a cross-sectional study or when calculating cumulativeincidence ratio without adjustment for time-to-event,prevalence/incidence ratio regression

    Presentation of p values, 95% confidence limits and standarderrors simultaneously is often redundant

    Be careful when comparing association strengths

    Stratified data instead of interaction terms (the latter areuseful for statistical testing and for predictive equations)

  • 8/12/2019 RIP-Szklo-3-26-09

    8/36

    Primary Prevention

    In a case-based case-control study, odds ratios instead ofbeta coefficients

    In a cross-sectional study or when calculating cumulativeincidence ratio without adjustment for time-to-event,

    prevalence/incidence ratio regression

    Presentation of p values, 95% confidence limits and standarderrors simultaneously is often redundant

    Be careful when comparing association strengths

    Stratified data instead of interaction terms (the latter areuseful for statistical testing and for predictive equations)

  • 8/12/2019 RIP-Szklo-3-26-09

    9/36

    Primary Prevention

    In a case-based case-control study, odds ratios instead of

    beta coefficients

    In a cross-sectional study or when calculating cumulativeincidence ratio without adjustment for time-to-event,prevalence/incidence ratio regression

    Presentation of p values, 95% confidence limits and standarderrors simultaneously is often redundant

    Be careful when comparing association strengths

    Stratified data instead of interaction terms (the latter areuseful for statistical testing and for predictive equations)

  • 8/12/2019 RIP-Szklo-3-26-09

    10/36

    Association of Center for Epidemiologic Studies Depression Scale

    (CES-D) scores (ln(CES-D + 1) with bereavement and baseline

    CES-D scores at 1 and 12-month interviews, adjusted for health

    and social network variables

    , widowed and married women aged65-74 yrs, Washington Co., MD, 1979-83

    1-month 12 months

    Factor SE t test SE t test

    o 0.76 0.10 7.9 0.74 0.09 8.3

    Widowed 1.93 0.15 13.3 0.31 0.10 3.2

    CES-D (baseline) 0.44 0.05 9.0 0.40 0.05 8.6

    CES-D * widowed -0.32 0.09 -3.8

    Self-reported health status, level of physical activity, family size and friendship

    size; p

  • 8/12/2019 RIP-Szklo-3-26-09

    11/36

    Center for Epidemiologic Studies Depression Scale (CES-D) Mean

    Baseline and Follow-up Scores According to Whether

    Bereavement Occurred, Women Ages 65-75 Years, Washington

    County, MD, 1979-1983

    0

    2

    4

    6

    8

    10

    12

    14

    16

    baseline 1 month 12 months

    married

    widowed

    *Adjusted for self-reported health status, level of phys. activity, family size

    and friendship size; Test for interaction between status and difference [1

    month baseline]: p

  • 8/12/2019 RIP-Szklo-3-26-09

    12/36

    Read carefully the Instructions to Authors (focus on maximumnumber of pages, other rules of presentation e.g., AjE requires aa

    to plot ratio-based measures on a log scale)

    Do not submit the same or similar publications to different journals

    Avoid abbreviations

    Description of results in text should follow the same order as in table

    Avoid the word, effect, when reporting observational results

    Make sure text, tables and figures match. When a result is presentedonly in the text, add parenthetically something like not shown intable/figure

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    13/36

    Read carefully the Instructions to Authors (focus on limit on numberof pages, other rules of presentation e.g., AjE requires aa to plot

    ratio-based measures on a log scale)

    Avoid abbreviations

    Description of results in text should follow the same order as in table

    Avoid the word, effect, when reporting observational results

    Make sure text, tables and figures match. When a result is presentedonly in the text, add parenthetically something like not shown in

    table/figure

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    14/36

    Read carefully the Instructions to Authors (focus on limit on numberof pages, other rules of presentation e.g., AjE requires aa to plot

    ratio-based measures on a log scale)

    Avoid abbreviations

    Description of results in text should follow the same order as in table

    Avoid the word, effect, when reporting observational results

    Make sure text, tables and figures match. When a result is presentedonly in the text, add parenthetically something like not shown in

    table/figure

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    15/36

  • 8/12/2019 RIP-Szklo-3-26-09

    16/36

    Read carefully the Instructions to Authors (focus on limit on numberof pages, other rules of presentation e.g., AjE requires aa to plot

    ratio-based measures on a log scale)

    Avoid abbreviations

    Description of results in text should follow the same order as in table

    Avoid the word, effect, when reporting observational results

    Make sure text, tables and figures match. When a result is presentedonly in the text, add parenthetically something like not shown in

    table/figure

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    17/36

    (Wang N et al, Am J Epidemiol 2009 [Epub ahead of print])

  • 8/12/2019 RIP-Szklo-3-26-09

    18/36

    Read carefully the Instructions to Authors (focus on limit on numberof pages, other rules of presentation e.g., AjE requires aa to plot

    ratio-based measures on a log scale)

    Avoid abbreviations

    Description of results in text should follow the same order as in table

    Avoid the word, effect, when reporting observational results

    Make sure text, tables and figures match. When a result is presentedonly in the text, add parenthetically something like not shown in

    table/figure

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    19/36

    Focus on trends, not just on testing or precision

    Do not repeat results in the text that are clearly shown in tables

    Discuss the studys limitations

    Paper should be as short as possible

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    20/36

    Focus on trends, not just on testing or precision

    Discuss the studys limitations

    Paper should be as short as possible

    Primary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    21/36

    Focus on trends, not just on testing or precision

    Discuss the studys limitations

    Paper should be as short as possible

    Primary Prevention

    Avoiding wordiness (Friedman AJE 1990;132:591)

  • 8/12/2019 RIP-Szklo-3-26-09

    22/36

    The amount ofmoney spent on diapers, without consideration of inflation,

    has been used as a proxy by several groups of

    investigators, and all have reported that no significant

    differences were observed once the data were stratified by

    age at last full term pregnancy. Similar results were found in

    the analysis and reported here. (73 words)

    Other investigations exploring the association between

    multiparity and scleroderma have obtained information on

    multiparity using surrogate measures.

    Shortened: Other investigators have used surrogate

    multiparity measures, such as amount spent on diapers,without inflation adjustment; as with our study, no

    significant differences were identified in data stratified by

    age at last full term pregnancy.(35 words)

    Avoiding wordiness (Friedman, AJE 1990;132:591)

  • 8/12/2019 RIP-Szklo-3-26-09

    23/36

    lleged letter from Mark Twain to a friend

    Dear

    I am sorry that I have written you such a long

    letter. I did not have any time to writeyou a short one

    S d P ti

  • 8/12/2019 RIP-Szklo-3-26-09

    24/36

    Responding to Reviewers Comments

    In your cover letter, answer each critique/comment made byreviewers.

    Highlight in the revised paper the changes made as a result of thereviewers comments.

    Be courteous. A good idea is to start your response with, I thank thereviewer for this thoughtful suggestion (that is, if you think it isthoughtful)

    Try to consider carefully each suggestion or comment.

    If you disagree somewhat with the request for a change, but it iseasy to implement it and it does not affect the sciencedo it!

    If you disagree entirely with a criticism and believe it is scientificallysound, explain why.

    Secondary Prevention:

    S d P ti

  • 8/12/2019 RIP-Szklo-3-26-09

    25/36

    Responding to Reviewers Comments

    In your cover letter, answer each critique/comment made byreviewers.

    Highlight in the revised paper the changes made as a result of thereviewers comments.

    Be courteous. A good idea is to start your response with, I thank thereviewer for this thoughtful suggestion (that is, if you think it isthoughtful)

    Try to consider carefully each suggestion or comment.

    If you disagree somewhat with the request for a change, but it iseasy to implement it and it does not affect the sciencedo it!

    If you disagree entirely with a criticism and believe it is scientificallysound, explain why.

    Secondary Prevention:

    S d P ti

  • 8/12/2019 RIP-Szklo-3-26-09

    26/36

    Responding to Reviewers Comments

    In your cover letter, answer each critique/comment made byreviewers.

    Highlight in the revised paper the changes made as a result of thereviewers comments.

    Be courteous. A good idea is to start your response with, I thank thereviewer for this thoughtful suggestion (that is, if you think it isthoughtful)

    Try to consider carefully each suggestion or comment.

    If you disagree somewhat with the request for a change, but it iseasy to implement it and it does not affect the sciencedo it!

    If you disagree entirely with a criticism and believe it is scientificallysound, explain why.

    Secondary Prevention:

    Secondary Prevention:

  • 8/12/2019 RIP-Szklo-3-26-09

    27/36

    Responding to Reviewers Comments

    In your cover letter, answer each critique/comment made byreviewers.

    Highlight in the revised paper the changes made as a result of thereviewers comments.

    Be courteous. A good idea is to start your response with, I thank thereviewer for this thoughtful suggestion (that is, if you think it isthoughtful)

    Try to consider carefully each suggestion or comment.

    If you disagree somewhat with the request for a change, but it iseasy to implement it and it does not affect the sciencedo it!

    If you disagree entirely with a criticism and believe it is scientificallysound, explain why.

    Secondary Prevention:

    Secondary Prevention:

  • 8/12/2019 RIP-Szklo-3-26-09

    28/36

    Responding to Reviewers Comments

    In your cover letter, answer each critique/comment made byreviewers.

    Highlight in the revised paper the changes made as a result of thereviewers comments.

    Be courteous. A good idea is to start your response with, I thank thereviewer for this thoughtful suggestion (that is, if you think it isthoughtful)

    Try to consider carefully each suggestion or comment.

    If you disagree with a request for a change, but it is easy toimplement it and it does not affect the sciencedo it!

    If you disagree entirely with a criticism and believe it is scientificallysound, explain why.

    Secondary Prevention:

    Secondary Prevention:

  • 8/12/2019 RIP-Szklo-3-26-09

    29/36

    Responding to Reviewers Comments

    In your cover letter, answer each critique/comment made byreviewers.

    Highlight in the revised paper the changes made as a result of thereviewers comments.

    Be courteous. A good idea is to start your response with, I thank thereviewer for this thoughtful suggestion (that is, if you think it isthoughtful)

    Try to consider carefully each suggestion or comment.

    If you disagree with a request for a change, but it is easy toimplement it and it does not affect the sciencedo it!

    If you disagree entirely with a criticism and believe it is scientificallysound, explain why.

    Secondary Prevention:

    Tertiary Prevention

  • 8/12/2019 RIP-Szklo-3-26-09

    30/36

    Tertiary Prevention

    Should authors request reconsideration if you paper has been rejected,

    and you believe that the reasons for rejection were not reasonable?

    I am sorry to inform you that after careful review, we are unable to accept yourpaper for publication. As you know, we can accept only a fraction of the meritorious

    manuscripts submitted to theAmerican Journal of Epidemiology. I appreciate the

    considerable effort that you and your colleagues have put into this manuscript and

    am sorry to bring you this unfavorable news.

    The comments of the reviewers are enclosed for your consideration. I hope the

    information provided by the reviewers will be helpful if you decide to revise the

    manuscript for submission to another journal. Please keep in mind that our

    decisions regarding acceptance of manuscripts are based not only on the

    reviewers' comments to the authors, but also on the reviewers' comments to

    the editor, in-house evaluations by editors, and an assessment of the priority

    rating of the manuscript in relation to our many other submissions.

    On behalf of the Journal, I thank you for submitting your manuscript and hope that

    the outcome of this specific review will not discourage you from sending future

    papers to us.

    Sincerely

  • 8/12/2019 RIP-Szklo-3-26-09

    31/36

    Decisions made for submissions to the AjE between

    1/1/08 and 6/30/08

    Accepted

    Total

    No.*No. not

    pending

    No. %

    Original contributions, meta-analysis

    and rapid communications

    510 382 29 8

    Practice of Epi 138 108 5 4

    Commentaries, Editorials and Special

    Articles

    23 21 11 52

    Reviews 9 4 1 25

    Letters to the Editor 29 25 19 76

    Book Reviews 5 5 5 100

    Total 714 545 70 13

  • 8/12/2019 RIP-Szklo-3-26-09

    32/36

    E-mail message from an European author uponreceiving a rejection letter:

    Dr. Szklo,

    What could I expect from an american (sic) editor? I

    will no longer buy american (sic) products.

    R t d j ti li f Chi

  • 8/12/2019 RIP-Szklo-3-26-09

    33/36

    Reputed rejection slip from a Chinese

    economics journal

    We have read your manuscript with boundless delight.

    If we were to publish your paper, it would be impossible

    for us to publish any work of a lower standard.

    And, as it is unthinkable that, in the next onethousand years, we shall see its equal,

    we are, to our regret, compelled to return your divine

    composition, and to beg you a thousand times to overlook our

    short sight and timidity.

  • 8/12/2019 RIP-Szklo-3-26-09

    34/36

  • 8/12/2019 RIP-Szklo-3-26-09

    35/36

    Adjusted* Risk (Hazard) Ratios of Coronary Heart Disease by

    Selected Factors, with 95% Confidence Intervals, Men 40-64 Yrs.

    Old at Baseline, 5-year Follow-up, 1975-79

    Factor Units Hazard Ratio

    Age 10 years 4.5

    Cholesterol 40 mg/dL 1.7

    Smoking Heavy smokers (20+

    cig/day) vs non-smokers

    3.1

    Family History Yes vs no 1.8

    *Each variable is simultaneously adjusted for all other variables

    seen in the table using Cox Proportional Hazards model

    Relative Risk of Pancreatic cancer in Relation to Drinks per Day by Gender

  • 8/12/2019 RIP-Szklo-3-26-09

    36/36

    Relative Risk of Pancreatic cancer in Relation to Drinks per Day by Gender

    in the NIH-AARP Diet and Health Study, USA, 1995/1996-2003


Recommended